{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:24:06Z","timestamp":1788449046740,"version":"build-2803163510"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"DOI":"10.3389\/fnagi.2018.00297","type":"journal-article","created":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T04:31:40Z","timestamp":1538368300000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides A\u03b21\u201342 and Tau Proteins in Elderly Patients With Mild Cognitive Impairment"],"prefix":"10.3389","volume":"10","author":[{"given":"Emmanuelle","family":"Duron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-S\u00e9bastien","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Grousselle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Gabelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Pasquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Bombois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Bu\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Allinquant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Schraen-Maschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Baret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Rigaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Epelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1373\/clinchem.2016.259275","article-title":"Plasma N-terminal prosomatostatin and risk of incident cardiovascular disease and all-cause mortality in a prospective observational cohort: the PREVEND study","volume":"63","author":"Abbasi","year":"2017","journal-title":"Clin. Chem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/brain\/awx365","article-title":"Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years","volume":"141","author":"Albert","year":"2018","journal-title":"Brain"},{"key":"B3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fnagi.2015.00030","article-title":"Regional and sub-regional differences in hippocampal GABAergic neuronal vulnerability in the TgCRND8 mouse model of Alzheimer\u2019s disease","volume":"7","author":"Albuquerque","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1001\/archneur.58.3.373","article-title":"Evaluation of CSF-tau and CSF-A\u03b242 as diagnostic markers for Alzheimer disease in clinical practice","volume":"58","author":"Andreasen","year":"2001","journal-title":"Arch. Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1523\/JNEUROSCI.09-12-04333.1989","article-title":"Neuropeptide Y in the cerebral cortex and the caudate-putamen nuclei: ultrastructural basis for interactions with GABAergic and non-GABAergic neurons","volume":"9","author":"Aoki","year":"1989","journal-title":"J. Neurosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1001\/archneur.1988.00520270043019","article-title":"Cerebrospinal fluid somatostatin and neuropeptide Y. Concentrations in aging and in dementia of the Alzheimer type with and without extrapyramidal signs","volume":"45","author":"Atack","year":"1988","journal-title":"Arch. Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.npep.2013.10.012","article-title":"Neuropeptides in learning and memory","volume":"47","author":"Borb\u00e9ly","year":"2013","journal-title":"Neuropeptides"},{"key":"B9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/cne.902600205","article-title":"Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold\/silver intensification on vibratome sections: coexistence with neuropeptide Y neurons and effects in Alzheimer-type dementia","volume":"260","author":"Chan-Palay","year":"1987","journal-title":"J. Comp. Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.neuroimage.2009.02.013","article-title":"Automatic segmentation of the hippocampus and the amygdala driven by hybrid constraints: method and validation","volume":"46","author":"Chupin","year":"2009","journal-title":"Neuroimage"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1001\/archpsyc.56.12.1135","article-title":"Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose","volume":"56","author":"Craft","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/288279a0","article-title":"Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa","volume":"288","author":"Davies","year":"1980","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000452131","article-title":"Association of neuropeptide Y gene rs16147 polymorphism with cardiovascular risk factors, adipokines, and metabolic syndrome in patients with obesity","volume":"9","author":"de Luis","year":"2016","journal-title":"J. Nutrigenet. Nutrigenomics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1136\/jnnp.2010.207183","article-title":"Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer\u2019s disease from other cortical dementias","volume":"82","author":"de Souza","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2217\/bmm.12.46","article-title":"Recommendations to standardize preanalytical confounding factors in Alzheimer\u2019s and Parkinson\u2019s disease cerebrospinal fluid biomarkers: an update","volume":"6","author":"del Campo","year":"2012","journal-title":"Biomark. Med."},{"key":"B16","volume-title":"DO 80 Epreuve de D\u00e9nomination Orale d\u2019images.","author":"Deloche","year":"1997"},{"key":"B17","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.nbd.2003.08.003","article-title":"Neuropeptide alterations in the hippocampal formation and cortex of transgenic mice overexpressing \u03b2-amyloid precursor protein (APP) with the Swedish double mutation (APP23)","volume":"14","author":"Diez","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/s0306-4522(00)00261-x","article-title":"Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F \u03b2-amyloid precursor protein\u2014initial observations","volume":"100","author":"Diez","year":"2000","journal-title":"Neuroscience"},{"key":"B19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.nbd.2016.07.022","article-title":"Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases","volume":"95","author":"Duarte-Neves","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2147\/VHRM.S1839","article-title":"Vascular risk factors, cognitive decline, and dementia","volume":"4","author":"Duron","year":"2008","journal-title":"Vasc. Health Risk Manag."},{"key":"B22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000107318","article-title":"Neuropeptides in cerebrospinal fluid of patients with Alzheimer\u2019s disease and dementia with frontotemporal lobe degeneration","volume":"4","author":"Edvinsson","year":"1993","journal-title":"Dementia"},{"key":"B25","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.jalz.2016.12.003","article-title":"Preclinical Alzheimer\u2019s disease: a systematic review of the cohorts underlying the concept","volume":"13","author":"Epelbaum","year":"2017","journal-title":"Alzheimers Dement."},{"key":"B23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.pneurobio.2009.07.002","article-title":"Somatostatin, Alzheimer\u2019s disease and cognition: an old story coming of age?","volume":"89","author":"Epelbaum","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/0006-8993(83)90277-9","article-title":"Somatostatin and dementia in Parkinson\u2019s disease","volume":"278","author":"Epelbaum","year":"1983","journal-title":"Brain Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3389\/fnagi.2017.00162","article-title":"Age-related gene expression in the frontal cortex suggests synaptic function changes in specific inhibitory neuron subtypes","volume":"9","author":"French","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3233\/JAD-121549","article-title":"Impact of the 2008\u20132012 French Alzheimer Plan on the use of cerebrospinal fluid biomarkers in research memory center: the PLM study","volume":"34","author":"Gabelle","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/0304-3940(93)90686-f","article-title":"Widespread deficits in somatostatin but not neuropeptide Y concentrations in Alzheimer\u2019s disease cerebral cortex","volume":"155","author":"Gabriel","year":"1993","journal-title":"Neurosci. Lett."},{"key":"B29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3233\/jad-2010-1385","article-title":"Expression of Somatostatin, cortistatin and their receptors, as well as dopamine receptors, but not of neprilysin, are reduced in the temporal lobe of Alzheimer\u2019s disease patients","volume":"20","author":"Gahete","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-8993(89)90424-1","article-title":"Subpopulations of somatostatin 28-immunoreactive neurons display different vulnerability in senile dementia of the Alzheimer type","volume":"490","author":"Gaspar","year":"1989","journal-title":"Brain Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1212\/wnl.38.6.900","article-title":"Screening for dementia by memory testing","volume":"38","author":"Grober","year":"1988","journal-title":"Neurology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1212\/wnl.54.4.827","article-title":"Memory impairment on free and cued selective reminding predicts dementia","volume":"54","author":"Grober","year":"2000","journal-title":"Neurology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/s0304-3940(98)00698-3","article-title":"Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele","volume":"255","author":"Grouselle","year":"1998","journal-title":"Neurosci. Lett."},{"key":"B34","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.jalz.2016.12.015","article-title":"Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers","volume":"13","author":"Handels","year":"2017","journal-title":"Alzheimers Dement."},{"key":"B35","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/s1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer\u2019s disease in patients with mild cognitive impairment: a follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1210\/jc.2016-1736","article-title":"N-terminal prosomatostatin as a risk marker for cardiovascular disease and diabetes in a general population","volume":"101","author":"Hedback","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B37","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/0006-3223(94)00239-y","article-title":"Cerebrospinal fluid neuropeptides in Alzheimer\u2019s disease and vascular dementia","volume":"38","author":"Heilig","year":"1995","journal-title":"Biol. Psychiatry"},{"key":"B38","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000479940","article-title":"N-terminal prosomatostatin and risk of vascular dementia","volume":"44","author":"Holm","year":"2017","journal-title":"Cerebrovasc. Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/jama.1963.03060120024016","article-title":"Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function","volume":"185","author":"Katz","year":"1963","journal-title":"JAMA"},{"key":"B40","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00702-005-0319-z","article-title":"Polymorphism in neuropeptide Y influences CSF cholesterol levels but is no major risk factor of Alzheimer\u2019s disease","volume":"113","author":"Kolsch","year":"2006","journal-title":"J. Neural Transm."},{"key":"B41","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/ana.410230202","article-title":"Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer\u2019s disease","volume":"23","author":"Kowall","year":"1988","journal-title":"Ann. Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/geront\/9.3_part_1.179","article-title":"Assessment of older people: self-maintaining and instrumental activities of daily living","volume":"9","author":"Lawton","year":"1969","journal-title":"Gerontologist"},{"key":"B43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/alzrt267","article-title":"A diagnostic scale for Alzheimer\u2019s disease based on cerebrospinal fluid biomarker profiles","volume":"6","author":"Lehmann","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"B44","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S1474-4422(08)70088-7","article-title":"Management of neurogenic orthostatic hypotension: an update","volume":"7","author":"Low","year":"2008","journal-title":"Lancet Neurol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/0006-8993(90)90082-m","article-title":"Neuropeptide Y receptor binding sites in human brain. Possible alteration in Alzheimer\u2019s disease","volume":"519","author":"Martel","year":"1990","journal-title":"Brain Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fendo.2012.00154","article-title":"Somatostatinergic systems: an update on brain functions in normal and pathological aging","volume":"3","author":"Martel","year":"2012","journal-title":"Front. Endocrinol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/bf02260903","article-title":"Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson\u2019s disease, multiple system atrophy and dementia of the Alzheimer type","volume":"4","author":"Martignoni","year":"1992","journal-title":"J. Neural Transm. Park Dis. Dement. Sect."},{"key":"B48","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.pbb.2010.11.019","article-title":"FK962 and donepezil act synergistically to improve cognition in rats: potential as an add-on therapy for Alzheimer\u2019s disease","volume":"98","author":"McCarthy","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1212\/WNL.0000000000004741","article-title":"Blood pressure from mid- to late life and risk of incident dementia","volume":"89","author":"McGrath","year":"2017","journal-title":"Neurology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s12021-016-9295-8","article-title":"CATI: a large distributed infrastructure for the neuroimaging of cohorts","volume":"14","author":"Operto","year":"2016","journal-title":"Neuroinformatics"},{"key":"B51","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nrn.2016.141","article-title":"Network abnormalities and interneuron dysfunction in Alzheimer disease","volume":"17","author":"Palop","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J. Intern. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13195-016-0190-1","article-title":"Exploring anterograde memory: a volumetric MRI study in patients with mild cognitive impairment","volume":"8","author":"Philippi","year":"2016","journal-title":"Alzheimers Res. Ther."},{"key":"B54","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1136\/jnnp.2005.085332","article-title":"Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer\u2019s disease","volume":"77","author":"Portet","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/j.neurobiolaging.2005.09.022","article-title":"Early neuropathology of somatostatin\/NPY GABAergic cells in the hippocampus of a PS1xAPP transgenic model of Alzheimer\u2019s disease","volume":"27","author":"Ramos","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"B56","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/acel.12605","article-title":"The space where aging acts: focus on the GABAergic synapse","volume":"16","author":"Rozycka","year":"2017","journal-title":"Aging Cell"},{"key":"B57","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nm1206","article-title":"Somatostatin regulates brain amyloid \u03b2 peptide A\u03b242 through modulation of proteolytic degradation","volume":"11","author":"Saito","year":"2005","journal-title":"Nat. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s00429-014-0771-3","article-title":"Interneurons, tau and amyloid-\u03b2 in the piriform cortex in Alzheimer\u2019s disease","volume":"220","author":"Saiz-Sanchez","year":"2015","journal-title":"Brain Struct. Funct."},{"key":"B59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.expneurol.2015.11.009","article-title":"Interneurons in the human olfactory system in Alzheimer\u2019s disease","volume":"276","author":"Saiz-Sanchez","year":"2016","journal-title":"Exp. Neurol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.007","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"key":"B61","doi-asserted-by":"publisher","first-page":"431.e1","DOI":"10.1016\/j.neurobiolaging.2010.12.014","article-title":"Interneuron loss reduces dendritic inhibition and GABA release in hippocampus of aged rats","volume":"33","author":"Stanley","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1001\/jamaneurol.2015.1285","article-title":"Longitudinal cerebrospinal fluid biomarker changes in preclinical Alzheimer disease during middle age","volume":"72","author":"Sutphen","year":"2015","journal-title":"JAMA Neurol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1212\/wnl.37.1.161","article-title":"Alzheimer\u2019s disease: low cerebral somatostatin levels correlate with impaired cognitive function and cortical metabolism","volume":"37","author":"Tamminga","year":"1987","journal-title":"Neurology"},{"key":"B64","volume-title":"Manuel d\u2019application de la Batterie Factorielle P.M.A (Primary Mental Activities). Adaptation fran\u00e7aise du Centre de Psychologie Appliqu\u00e9e.","author":"Thurstone","year":"1964"},{"key":"B65","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/s0887-6177(03)00039-8","article-title":"Trail making test A and B: normative data stratified by age and education","volume":"19","author":"Tombaugh","year":"2004","journal-title":"Arch. Clin. Neuropsychol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"e34376","DOI":"10.1371\/journal.pone.0034376","article-title":"Somatostatin modulates insulin-degrading-enzyme metabolism: implications for the regulation of microglia activity in AD","volume":"7","author":"Tundo","year":"2012","journal-title":"PLoS One"},{"key":"B67","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/bf00299414","article-title":"NADPH-diaphorase-positive cell populations in the human amygdala and temporal cortex: neuroanatomy, peptidergic characteristics and aspects of aging and Alzheimer\u2019s disease","volume":"83","author":"Unger","year":"1992","journal-title":"Acta Neuropathol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1515\/cclm.2006.258","article-title":"Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer\u2019s disease and dementia with Lewy bodies","volume":"44","author":"Vanderstichele","year":"2006","journal-title":"Clin. Chem. Lab. Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1126.e1","DOI":"10.1016\/j.neurobiolaging.2011.11.024","article-title":"A new neuronal target for \u03b2-amyloid peptide in the rat hippocampus","volume":"33","author":"Villette","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"B70","doi-asserted-by":"publisher","first-page":"10991","DOI":"10.1523\/JNEUROSCI.6284-09.2010","article-title":"Decreased rhythmic GABAergic septal activity and memory-associated theta oscillations after hippocampal amyloid-\u03b2 pathology in the rat","volume":"30","author":"Villette","year":"2010","journal-title":"J. Neurosci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e28401","DOI":"10.7554\/elife.28401","article-title":"Somatostatin binds to the human amyloid \u03b2 peptide and favors the formation of distinct oligomers","volume":"6","author":"Wang","year":"2017","journal-title":"Elife"},{"key":"B72","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3233\/jad-2009-1165","article-title":"Effects of insulin and octreotide on memory and growth hormone in Alzheimer\u2019s disease","volume":"18","author":"Watson","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1523\/JNEUROSCI.5066-07.2008","article-title":"Progression of amyloid pathology to Alzheimer\u2019s disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase 2","volume":"28","author":"Wilcock","year":"2008","journal-title":"J. Neurosci."},{"key":"B74","first-page":"709","article-title":"Geriatric depression scale","volume":"24","author":"Yesavage","year":"1988","journal-title":"Psychopharmacol. Bull."}],"updated-by":[{"DOI":"10.3389\/fnagi.2019.00011","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T00:00:00Z","timestamp":1550534400000}}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnagi.2018.00297\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T09:49:24Z","timestamp":1550569764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnagi.2018.00297\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":74,"alternative-id":["10.3389\/fnagi.2018.00297"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2018.00297","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fnagi.2019.00011","asserted-by":"object"}]},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,1]]},"article-number":"297"}}